Gaush Meditech Ltd (HKG: 2407), a company based in Suzhou, has announced that it has received market approval from the National Medical Products Administration (NMPA) for its rigid corneal contact lens. This development marks a significant step forward for the company, as it now offers a highly rigid gas permeable contact lens (RGP) as a correction method for non-progressive myopia.
RGP Lens as a Correction Method
Rigid corneal contact lenses are an ideal solution for patients with high myopia, high hyperopia, high astigmatism, irregular astigmatism, anisometropia, and keratoconus. These lenses are crafted from materials that offer high oxygen permeability, which is crucial for maintaining ocular health and safety during extended wear.
Benefits of Gaush Meditech’s RGP Lens
The high vision medical rigid corneal contact lenses from Gaush Meditech feature a patented design that enhances visual quality and promotes peripheral tear exchange. This design not only improves the overall wearing experience but also reduces the foreign body sensation for first-time wearers, making the lenses more comfortable and safe to use.-Fineline Info & Tech
